Free

DiscoveryLab Business Plan Session

Event Information

Share this event

Date and Time

Location

Location

NANUC (NAtional NUclear Magnetic Resonance Centre)

University of Alberta

(behind HMRC and Li Ka Shing buildings at 112 St and 87 Ave)

Edmonton, AB T6G 1Z1

Canada

Event description

Description

Business Plan Session (1:30-5:30pm)

Pitch your plan to a panel of experts in 10 minutes and receive free advice on progressing your valuable ideas. Send a non-technical, non-condidential executive summary of your plan to qualify. This will be shared with the panel members only. Propositions in any stage, technology or field are welcome, as long as there is a pathway to provide value to society. A panel of advisors from TEC Edmonton, experts in intellectual property law and investors will be on hand to offer suggestions and discuss your plans with you in a supportive round-table format.

Website: www.discoverylab.ca

Public Transportation: The University and Health Sciences Light Rail Train Stations are a few minutes’ walk.

Parking is available just south of 87 Ave. on the west side of 112 St, and in parking lots on campus including the Timms/Telus Centre (87 Ave & 112 St) and Education Carpark (87 Ave & 114 St). There is limited street parking on the east side of 87 Ave in Garneau.

Agenda

Presenters may be academic researchers, clinical scientists, or directors of spin outs or SMEs, and will be asked to present their unique edge, market leading position, team/partners, type of intellectual property, business strategy, products/services to be developed, investment needed, and timeframe for delivery and exit. Presenters are asked to identify 1 or 2 questions or key issues they would like advice on.

Schedule

1:30-1:45 pm Expert Panel convenes over coffee to discuss brief proposals

1:45-2:30 pm Team 1

2:30-3:15 pm Team 2

3:15-3:30 pm Break

3:30-4:15 pm Team 3

4:15-5:00 pm Team 4

5:00-5:15 pm Break

5:15-5:30 pm Elevator pitches

Format:

The panel will first meet in private to discuss the purpose, agenda and executive summaries. Each team meets with the entire panel of about 5-8 experts for a closed (non-public) round table discussion, with each team giving short presentation, followed by Q&A, evaluation of the team, presentation and plan, and a reception. The aim is to encourage exchange of ideas and contacts. Advisors are requested to provide constructive advice to the individuals, spin outs and small companies presenting who may have intellectual property and initial funding for commercial development but are looking for expert support and guidance at a vulnerable stage of translating their innovations into useful solutions or scaling their business.

Panel Members

Brett Clelland joined Parlee McLaws LLP as an associate in 2015, after working as a summer student and completing his articles with the firm. His practice is focused on the area of intellectual property law. During his articling year, Brett gained experience in the preparation and prosecution of patent, trademark and industrial design applications, providing patent and trademark opinions, trademark opposition proceedings, and copyright matters. Prior to entering the legal field, Brett graduated with a Ph.D. from the University of Alberta, where his research experience encompassed the areas of molecular biology, protein and nucleic acid biochemistry, and microbiology. Following this, Brett attended law school in order to pursue a career in intellectual property.

Carmen Wyton, Founder & President of Ripple Enterprise, has 25 years experience in the non-profit sector – in health, human services, disabilities, education and employment. Areas of expertise include experience in strategic planning, government relations, policy influence, stakeholder relations, fund development, formation of sustainable relationships with stakeholders, and identifying innovative solutions with measurable outcomes and high return on investment. She has worked on policy development, advocacy and government relations in health, pharmaceuticals, non-profit, recreation and disability sectors.

Colin Coros is a TEC Edmonton Executive in Residence, and specializes in life sciences and providing mentorship in areas of health sciences, company mentoring, and strategic consulting. As the CEO of the Delta Genomics Centre, Colin built a national biobanking, genotyping and sequencing company for the livestock industry. He is also the co-founder of Helios Genomics, a metagenomics company specializing in the Energy sector, and former executive of Livestock Gentec. Colin holds a PhD in Biochemistry from the University of Western Ontario, an MBA from University of Saskatchewan’s Edward School of Business, and completed postdoctoral studies at the Wadsworth Centre in Albany, New York, and the University of Calgary.

Cory Janssen is President of Galt Capital, a private investment firm, and co-founder of Janalta Interactive, an online media company. He is also a director at Brace Tool Inc, a private oilfield tools company. He was a co-founder of Investopedia.com, a financial education site that provided content and tools to help educate individual investors. Cory is past-President of the Edmonton chapter for Entrepreneur’s Organization (EO) and active in the Edmonton entrepreneurial community as a member of the A100 as well as the Venture Mentoring Service (VMS) program at the University of Alberta. Through Janalta Interactive, Cory is in startup mode again with a new machine learning venture to help solve old problems in new ways.

Harold Jahn is the founder and sole shareholder of Prosperity Investments LLC. He has over 30 years of international business experience in the industries of renewable energy, internet, mining, energy, real estate development, fintech, and commercialization of new technologies. He has developed an extensive network of professionals globally in industry, locally, and politically to ensure successful ventures. His long term goal is to create a minimum of 1,000 full time positions per annum in smaller communities throughout the US and Canada.

Joanna Preston is Associate Director of the Technology Management team (Health Sciences) at TEC Edmonton, and oversees the provision of IP management and commercialization services to local inventors in the health sciences area. She spent a decade in production roles in the biomanufacturing industry, first with a private Alberta firm, and later with the Alberta Research Council. She holds a Bachelor of Science in Genetics and an MBA in Technology Commercialization, both from the University of Alberta. Joanna is a member of the Association of University Technology Managers and the Licensing Executive Society. She is also a case study discussion leader for the Canadian Intellectual Property Office and a grant reviewer for the Canadian Institute of Health Research.

Mark Benning is an experienced entrepreneur who founded and led four investor-backed, technology startups in Silicon Valley, California over a 20-year period. As an Executive in Residence at TEC Edmonton since 2017, he acts as a mentor to entrepreneurs and executives and as an advisor to TEC’s Business Development team. Over the years, he has worked for various private equity and venture capital firms and has raised over $100 million in angel and venture funding for his startups and others he advised. He has a BA in Economics from Harvard University and an MBA from Stanford University, where he focused on leadership and entrepreneurship.

Ray Muzyka is the CEO & Founder of ThresholdImpact. He originally trained as a medical doctor, and cofounded and was CEO of BioWare, a video game development studio. BioWare was acquired by Electronic Arts in 2007, and Dr. Muzyka took on the roles of Senior Vice President at Electronic Arts and General Manager of EA’s BioWare division. At ThresholdImpact he focused on sustainable, profitable impact investing: mentoring and angel investing in information technology, new media, and medical innovations with social entrepreneurs. An active angel investor and entrepreneurial mentor, he is a member of the Young Presidents’ Organization, the A100, the Ashoka Support Network. He is Chair of the University of Alberta’s entrepreneur Venture Mentoring Service and a venture advisor at iNovia Venture Capital.

Ryan Heit has a diverse background in research, technology commercialization, business development, and financing early stage companies. Ryan has provided business planning and company development for many early-stage, technology-based ventures in health-related fields in his position at TEC Edmonton and as an independent consultant. Additionally, he has helped multiple Alberta companies in obtaining financing in his role with the angel investing network, TEC VA. He received his Masters in Experimental Oncology and his Masters of Business Administration with a specialization in Technology Commercialization from the University of Alberta.

Sameeh M. Salama, Vice-President of Business Development at Brass Dome Ventures ltd., and VP of Fedora Pharmaceuticals Inc. He was formerly VP of NAEJA Pharmaceuticals Inc. where he was involved in over a dozen licensing and partnership agreements, including the licensing of NAEJA’s Beta-lactamase inhibitors to Fedora Pharmaceuticals Inc. and later the licensing of the same assets to F. Hoffman La Roche in a US$750 million deal. Dr. Salama was previously a Director of Microbiology at SynPhar laboratories Inc. He received his PhD in Medical Microbiology from the University of Salford, U.K. and postdoc’d at the University of Alberta.

Scott Reed is the Director, Business Development at Brass Dome Ventures . He obtained his Chartered Financial Analyst designation in 2007 and his MBA in 2013. He has been working in the financial and consulting industry since 2002. He has worked in both small and large organizations and has a variety of experience.

Ted Yoo, Partner at Bennett Jones, is a registered patent and trademark agent in both Canada and the United States. His practice covers all matters related to intellectual property (IP), but is particularly focused on the preparation and prosecution of patent applications, licensing, patentability and freedom to operate opinions, and IP review in support of financings, and mergers and acquisitions. With a background in microbiology and chemistry, and an enduring personal interest in all areas of technology, Ted acts for clients in the fields of biotechnology, nanotechnology, pharmaceuticals, forestry and agriculture, and the oil and gas industry. In particular, Ted has significant experience with pharmaceuticals, advanced materials, fuel cells, fertilizer production, upstream, midstream and downstream petroleum technology, and computer-related inventions. He is a Sessional Lecturer in IP Law at the Faculty of Law, University of Alberta and has lectured in the Faculty of Engineering, University of Alberta.

Share with friends

Date and Time

Location

NANUC (NAtional NUclear Magnetic Resonance Centre)

University of Alberta

(behind HMRC and Li Ka Shing buildings at 112 St and 87 Ave)

Edmonton, AB T6G 1Z1

Canada

Save This Event

Event Saved